Trials / Completed
CompletedNCT05679453
Lornoxicam Versus Etodolac After Third Molar Surgery
Comparison of Lornoxicam and Etodolac on Edema, Trismus and Pain After Third Molar Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Kutahya Health Sciences University · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Our study aimed to compare the effect of lornoxicam and etodolac on postoperative pain, edema and trismus following lower third molar extraction
Detailed description
20 patients included in study (4 male, 16 female). Lornoxicam and etodolac was given following lower third molar extraction. Pain was evaluated 2., 6., 12., 24., and 48. hours using VAS. Edema was evaluated by measuring tragus-labial commissure, angulus- lateral canthus of eye and angulus mandible-labial commissure. Trismus was evaluated measuring mouth opening by caliper. Edema and Trismus was evaluated by 48. and 168. hours
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lornoxicam 8 Mg Oral Tablet | Lornoxicam is a oxicam grup non-steroid antiinflamatuar drug |
Timeline
- Start date
- 2022-07-20
- Primary completion
- 2022-09-25
- Completion
- 2022-09-29
- First posted
- 2023-01-11
- Last updated
- 2023-01-11
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05679453. Inclusion in this directory is not an endorsement.